comparison
intraparticip
varianc
shown
sequenti
blandaltman
plot
fig
articl
onlin
repositori
wwwjacionlineorg
consist
low
variabl
periostin
level
within
subject
clinic
sampl
repres
wellcontrol
adult
asthmat
popul
ci
individu
predict
periostin
level
plu
minu
ngml
mean
coeffici
variat
periostin
particip
ci
evid
monthli
p
see
tabl
articl
onlin
repositori
wwwjacionlineorg
season
p
see
tabl
articl
onlin
repositori
wwwjacionlineorg
variat
particip
five
particip
sever
asthma
exacerb
studi
requir
system
corticosteroid
fig
mean
dose
mgd
rang
mgd
cours
last
day
see
tabl
articl
onlin
repositori
wwwjacionlineorg
mix
linear
model
estim
differ
periostin
level
first
measur
sever
exacerb
requir
system
corticosteroid
preexacerb
measur
particip
ngml
ci
ngml
p
differ
periostin
level
postexacerb
preexacerb
level
ngml
ci
ngml
p
smaller
ci
individu
predict
periostin
level
summari
found
littl
variabl
periostin
measur
within
subject
period
withinparticip
varianc
ci
periostin
level
ngml
find
adult
receiv
step
treatment
accord
global
initi
asthma
guidelin
consist
studi
perform
popul
sever
asthma
period
week
respect
studi
report
coeffici
variat
rather
varianc
compon
point
estim
respect
consist
low
intraparticip
variabl
periostin
measur
observ
studi
coeffici
variat
found
evid
monthli
season
fluctuat
serum
periostin
level
particip
recruit
period
therefor
might
necessari
consid
season
assess
periostin
level
candid
treatment
novel
asthma
biolog
therapi
periostin
level
modestli
reduc
system
corticosteroid
treatment
sever
asthma
exacerb
effect
lie
within
level
variat
expect
otherwis
stabl
adult
asthma
conclus
propos
stabil
periostin
measur
support
use
biomark
asthmat
patient
predict
respons
biolog
therapi
direct
type
diseas
boy
nonsever
skin
lung
infect
homozyg
intron
mutat
produc
novel
splice
acceptor
site
result
predomin
express
frameshift
mutant
protein
residu
level
wildtyp
wt
protein
recent
sibl
pair
manifest
earlyonset
autoimmun
diseas
without
opportunist
infect
shown
compound
heterozyg
hypoact
allel
weakli
hyperact
allel
specif
combin
pair
allel
requir
diseas
collect
case
show
residu
level
function
protein
regul
clinic
phenotyp
defici
suggest
distinct
null
allel
differ
therapeut
approach
may
need
leaki
mutat
permit
surviv
beyond
typic
time
frame
hematopoiet
stem
cell
transplant
older
age
may
associ
excess
risk
expand
clinic
phenotyp
hypomorph
defici
provid
proofofconcept
mutationtarget
therapi
improv
immun
function
identifi
male
born
consanguin
coptic
parent
see
fig
articl
onlin
repositori
wwwjacionlineorg
older
brother
die
month
suspect
viral
enceph
older
sister
parent
well
histori
failur
thrive
adren
insuffici
inflammatori
enterocol
start
infanc
recurr
respiratori
tract
infect
start
month
intermitt
mucocutan
candidiasi
recurr
herp
simplex
viru
stomat
varicellazost
viru
infect
time
investig
time
reveal
visibl
thymu
normal
immunoglobulin
isotyp
poor
respons
vaccin
persist
lymphocytopenia
total
cell
ageadjust
refer
rang
begin
approxim
year
age
serial
test
demonstr
increas
proport
cell
total
lymphocyt
investig
suggest
defici
fig
b
c
howev
refer
laboratori
report
identifi
mutat
thu
bone
marrow
transplant
pursu
iga
nephropathi
age
year
eventu
requir
renal
transplant
mother
age
year
subsequ
year
mark
ebv
viremialymphoprolif
disord
recurr
viremia
month
complet
rituximab
cytomegaloviru
viremia
recurr
follow
cessat
val
ganciclovir
polyomaviremia
bk
jc
virus
epidermodysplasia
verruciformislik
lesion
due
human
papilloma
see
fig
articl
onlin
repositori
wwwjacionlineorg
prompt
reevalu
underli
immunodefici
current
age
year
immunoglobulin
replac
respiratori
tract
infect
prophylaxi
viral
infect
manag
conserv
wholeexom
sequenc
reveal
known
etiolog
immunodefici
homozyg
variant
germlin
variant
synonym
predict
silico
human
splice
finder
creat
novel
donor
splice
site
within
exon
dss
mut
stronger
nativ
junction
one
dss
wt
fig
new
splice
site
predict
creat
delet
product
prematur
stop
codon
exon
sanger
sequenc
confirm
homozyg
variant
unaffect
famili
member
heterozyg
fig
b
rtpcr
pbmc
confirm
predict
splice
effect
demonstr
predomin
mutant
isoform
trace
level
wt
isoform
fig
c
heterozyg
famili
member
possess
isoform
higher
wt
level
unrel
healthi
control
express
wt
isoform
sequenc
gelelut
band
confirm
delet
mutant
isoform
data
shown
thu
variant
creat
mutant
mrna
isoform
aberr
splice
homozyg
state
mutant
isoform
predomin
wt
determin
impact
predomin
aberr
mrna
isoform
protein
product
perform
immunoblot
analysi
pbmc
confirm
reduc
level
seen
origin
childhood
investig
fig
c
plasmid
encod
openread
frame
wt
wt
delet
variant
mut
stabli
transfect
jurkat
cell
immunoblot
cell
lysat
confirm
absenc
protein
mutant
isoform
fig
e
tcr
signal
downstream
assess
phosphoryl
linker
activ
cell
absent
follow
stimul
mut
transfect
jurkat
intact
wt
see
fig
b
articl
onlin
repositori
wwwjacionlineorg
find
confirm
mutant
mrna
result
variant
null
although
mutant
donor
splice
site
dss
mut
stronger
nativ
wt
site
dss
wt
latter
still
intact
function
abl
gener
wt
mrna
protein
homozyg
mutant
state
clearli
inadequ
tcell
homeostasi
howev
heterozyg
famili
member
wt
protein
suffici
produc
maintain
otherwis
well
state
hypothes
block
stronger
dss
mut
would
favor
usag
dss
wt
increas
wt
level
consequ
tcell
function
prove
design
antisens
morpholino
oligonucleotid
amo
target
variant
spare
nativ
exonintron
junction
block
mutant
splice
effect
process
premrna
fig
f
confirm
amo
specif
inhibit
express
mutant
isoform
ie
block
transit
premrna
mrna
treat
pbmc
demonstr
correct
splice
fig
g
optim
studi
demonstr
maxim
correct
effect
start
hour
use
mm
amo
produc
approxim
wt
mrna
confirm
sequenc
data
shown
similar
amoinduc
effect
mutant
mrna
seen
sister
cell
data
shown
insuffici
number
cell
parent
test
verifi
specif
effect
treat
cell
healthi
control
observ
effect
data
shown
immunoblot
analysi
amotr
pbmc
demonstr
increas
express
confirm
correct
aberr
splice
result
augment
product
protein
fig
b
amotr
pbmc
demonstr
increas
linker
activ
cell
activ
follow
stimul
compar
untreat
cell
fig
b
indic
restor
retain
function
intact
tcr
signal
determin
whether
amo
could
improv
cellular
function
evalu
express
prototyp
tcell
cytokin
gene
ifng
ifng
fig
c
amo
treatment
alon
increas
express
express
enhanc
stimul
fig
c
treatment
amo
effect
ifng
express
data
shown
like
due
reestablish
h
respons
pbmc
polar
away
h
respons
last
amo
treatment
reestablish
prolif
respons
costimul
primari
cell
effect
seen
cell
fig
express
wt
protein
molecularli
intact
capabl
restor
key
tcell
function
respons
analysi
hypomorph
patient
uniqu
illustr
sever
key
point
clinic
morbid
natur
histori
suggest
role
function
control
doublestrand
dna
virus
beyond
gener
cell
requir
elucid
interestingli
autoimmun
diseas
coliti
nephropathi
also
report
chan
et
al
elegantli
demonstr
fine
molecular
balanc
effect
tcell
signal
associ
autoimmun
genet
show
synonym
genet
variant
may
deleteri
modifi
splice
hypomorph
result
skew
net
balanc
amorph
versu
residu
wt
protein
immunotherapeut
demonstr
accur
identif
causal
genet
lesion
permit
mutationsilenc
approach
lead
molecular
correct
recuper
fundament
tcell
cytokin
respons
least
vitro
although
breadth
tcell
function
could
fulli
investig
pragmat
knowledg
repres
first
exampl
amo
therapi
success
restor
immun
function
primari
cell
human
genet
defin
immunodefici
approach
could
also
extend
therapeut
modul
function
singlenucleotid
polymorph
immun
gene
clearli
addit
paramet
need
address
approach
use
clinic
practic
eg
pharmacokinet
safeti
although
strategi
use
inborn
error
muscl
metabol
overal
insight
gain
work
open
new
avenu
individu
mutationtarget
therapi
cid
editor
periostin
extracellular
protein
emerg
novel
mediat
allerg
diseas
play
import
role
tissu
remodel
serum
periostin
biomark
elev
sever
eosinophil
asthma
aspirinexacerb
respiratori
diseas
level
predict
develop
airflow
limit
patient
asthma
inhal
corticosteroid
well
respons
omalizumab
lebrikizumab
uncontrol
sever
allerg
asthma
howev
despit
clinic
signific
mechan
periostin
regul
inflamm
remain
poorli
understood
pathogenesi
airway
inflammatori
diseas
chronic
rhinosinus
cr
one
common
chronic
rhinolog
diseas
significantli
reduc
qualiti
life
affect
subject
increas
periostin
product
sinonas
tissu
occur
subject
cr
particularli
j
allergi
clin
immunol
may
subject
patient
famili
member
provid
inform
consent
mcgill
univers
health
centr
institut
review
boardapprov
research
protocol
comprehens
medic
histori
includ
review
avail
outsid
record
serial
clinic
evalu
clinic
immunolog
laboratori
test
perform
mcgill
univers
health
centr
h
ex
vivo
enumer
h
enumer
whole
blood
perform
previous
describ
wholeexom
sequenc
exom
enrich
conduct
genom
dna
use
seqcap
ez
exom
utr
kit
sequenc
captur
rochenimblegen
madison
wi
enrich
genom
dna
fragment
sequenc
illumina
hiseq
wholeexom
sequenc
data
analyz
follow
gatk
best
practic
recommend
variant
discoveri
dnaseq
gatk
version
verifi
qualiti
read
fastqc
read
align
burrowswheel
align
refer
genom
duplic
read
mark
picard
tool
read
realign
around
indel
gatk
indelrealign
base
qualiti
score
recalibr
gatk
baserecalibr
variant
call
perform
gatk
haplotypecal
variant
annot
perform
snpsift
snpeff
variant
coverag
least
read
kept
downstream
analysi
identifi
rare
variant
frequenc
variant
exom
aggreg
consortium
databas
verifi
sanger
sequenc
gene
pcr
amplifi
genom
dna
use
primer
design
flank
respect
region
primer
sequenc
condit
avail
request
sequenc
perform
mcgill
univers
g
enom
qu
ebec
innov
centr
sequenc
analys
perform
sequench
sequenc
analysi
softwar
gene
code
corpor
ann
arbor
mich
potenti
splice
site
predict
use
onlin
tool
human
splice
finder
wwwumdbehsf
mycflagtag
plasmid
origen
rockvil
md
sitedirect
mutagenesi
use
creat
delet
end
exon
new
england
biolab
whitbi
ontario
canada
jurkat
jurkat
cell
stabli
transfect
either
wt
mutant
plasmid
electropor
follow
select
mgml
amo
design
target
de
novo
mutant
donor
splice
site
gener
mutat
premrna
spare
nativ
donor
splice
site
amo
sequenc
follow
vivomorpholino
use
concentr
mm
amo
design
synthes
genetool
llc
philomath
ore
pbmc
isol
previous
describ
pbmc
cultur
optimem
reduc
serum
media
thermo
scientif
waltham
mass
stimul
mgml
follow
mgml
secondari
antibodi
ad
roundbottom
plate
coat
mgml
mgml
insuffici
number
cell
sister
parent
function
test
sampl
acquir
bd
facscanto
ii
flow
cytomet
singlecolor
compens
sampl
prepar
use
abc
total
antibodi
compens
bead
kit
thermo
scientif
cell
label
celltrac
cfse
cell
prolifer
kit
thermo
scientif
livedead
fixabl
cell
stain
kit
thermo
scientif
per
manufactur
instruct
compens
analysi
perform
flowjo
version
sampl
separ
bistri
polyacyrlamid
gel
thermo
scientif
transfer
onto
polyvinyliden
difluorid
membran
immunoblot
band
densiti
measur
imagej
softwar
http
imagejnihgovij
antibodi
phosphoryl
linker
activ
cell
bactin
cell
signal
technolog
danver
mass
total
linker
activ
cell
antibodi
santa
cruz
biotechnolog
dalla
texa
antiflag
origen
antibodi
biolegend
san
diego
calif
antibodi
lck
fyn
csk
describ
previous
allophycocyaninconjug
antihuman
thermo
scientif
phycoerythrinconjug
antihuman
bd
bioscienc
mississauga
ontario
canada
total
rna
isol
use
rneasi
kit
qiagen
mississauga
ontario
canada
revers
transcrib
maxima
cdna
synthesi
kit
rtquantit
pcr
thermo
scientif
quantit
realtim
pcr
perform
use
taqman
quantit
pcr
gene
express
assay
system
probe
direct
assay
id
assay
id
assay
id
assay
id
assay
id
thermo
scientif
appli
biosystem
realtim
pcr
system
mrna
input
normal
express
tcellspecif
housekeep
gene
account
variabl
tlymphocyt
composit
one
experi
repres
independ
experi
perform
shown
graph
statist
analys
gener
graphpad
prism
version
statist
signific
calcul
accord
unpair
ratio
student
test
p
consid
signific
